GSK

Contact
glaxosmithkline.at
+43197075-0

GlaxoSmithKline Pharma GmbH

Albert Schweitzer-Gasse 6
1140 Wien
Austria
+43197075-0
glaxosmithkline.at
Contact
Profile Products News
Contact

About GSK

We are a global research, research and science-oriented healthcare company. We are researching and developing a wide range of innovative products in our three main divisions, Pharmaceuticals, Vaccines and Consumer Healthcare.

Read more about GSK
Facts about GSK
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of GSK

Product portfolio

Show all

News about GSK

GSK

12-Apr-2022 | politics & laws

CureVac and GSK Enter into Pandemic Preparedness Contract with German Government

Five-year contract enables production of up to 80 million vaccine doses at short notice in case of a public health emergency

Read news
GSK

01-Apr-2022 | research and development

CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate

CureVac N.V. announced that the first participant was dosed in a Phase 1 study of COVID-19 second-generation mRNA vaccine candidate, CV2CoV, developed in ...

Read news
GSK

03-Feb-2021 | business & finance

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

Development to begin immediately targeting vaccine availability in 2022

Read news
GSK

21-Jul-2020 | business & finance

GSK and CureVac announce strategic mRNA technology collaboration

Companies to collaborate on mRNA vaccine and monoclonal antibody research programmes in infectious diseases

Read news
GSK

15-Apr-2020 | research and development

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

Companies have set up a Joint Task Force

Read news
GSK

20-Dec-2018 | business & finance

GlaxoSmithKline plc and Pfizer Inc to form new Consumer Healthcare Joint Venture

GlaxoSmithKline plc has reached agreement with Pfizer Inc to combine their consumer health businesses into a new Joint Venture, with combined sales of ...

Read news
GSK

13-Apr-2018 | business & finance

GSK transfers rare disease gene therapy portfolio

GSK and Orchard Therapeutics announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene ...

Read news
GSK

27-Mar-2018 | business & finance

Novartis to sell stake in consumer healthcare joint venture to GSK

Focussing on strategic priorities

Read news
Show more news about GSK

Here you will find GlaxoSmithKline Pharma GmbH